Latest News | Biocon Biologics' Bengaluru Unit Classified as Voluntary Action Indicated by USFDA

New Delhi, Oct 30 (PTI) Biocon Biologics on Wednesday said its drug substance facility in Bengaluru has been classified as voluntary action indicated by the US Food and Drug Administration.

Biocon Biologics' drug substance facility is located at Biocon Campus, (Site 1) in Bengaluru, the company said in a statement.

Also Read | Punjab State Dear Diwali Bumper Lottery 2024: Ticket Price, Draw Result Date and Time, Prize Money Details – Know Everything Here.

"This relates to the cGMP inspection conducted by the agency between February 20-28, 2024 and pertains to the supply of rh-Insulin (rhI) drug substance to the United States," it added.

Biocon Biologics remains committed to global standards of quality and compliance, the company said.

Also Read | Latest Government Jobs Notifications: IIT Hyderabad Invites Applications for 31 Non-Teaching Posts, Know Recruitment Process, Eligibility and Steps to Apply.

Under voluntary action indicated (VAI), while objectionable conditions were found and documented during an inspection, the agency is not prepared to take or recommend regulatory action, as per the USFDA.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)